CORVUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 1st, 2018 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 1st, 2018 Company Industry JurisdictionThis Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Daniel Hunt (“Executive”) and Corvus Pharmaceuticals, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
CORVUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 4th, 2016 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 4th, 2016 Company Industry JurisdictionThis Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Jason Coloma (“Executive”) and Corvus Pharmaceuticals, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
CORVUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 4th, 2016 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 4th, 2016 Company Industry JurisdictionThis Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between William B. Jones (“Executive”) and Corvus Pharmaceuticals, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
CORVUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 4th, 2016 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 4th, 2016 Company Industry JurisdictionThis Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Erik J. Verner (“Executive”) and Corvus Pharmaceuticals, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).